Appointment booking for Dr. Christopher Weese, MD is currently not available.Dr. Christopher Weese, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Christopher Weese, MD (he/him) is a Internist in Lancaster, PA with over 13 years of experience. What is your opinion of Dr. Christopher Weese, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 13 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Christopher Weese, MD has received over $872 which includes payments from the following companies:
$111.83 from Novartis Pharmaceuticals Corporation
$100.99 from Pfizer Inc.
$92.13 from Boehringer Ingelheim Pharmaceuticals, Inc.
$91.56 from Alexion Pharmaceuticals, Inc.
$86.90 from E.R. Squibb & Sons, L.L.C.
$68.05 from Sunovion Pharmaceuticals Inc.
$57.79 from Allergan Inc.
$57.06 from Advanced Respiratory, Inc
$46.56 from Janssen Pharmaceuticals, Inc
$38.80 from ResMed Corp
$29.89 from Mallinckrodt Enterprises LLC
$24.69 from Vyera Pharmaceuticals, LLC
$19.58 from Mallinckrodt LLC
$16.50 from sanofi-aventis U.S. LLC
$16.35 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$14.17 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
Payments received by Dr. Christopher Weese, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!